Humacyte, Inc. (HUMA)
NASDAQ: HUMA · Real-Time Price · USD
0.6479
-0.0525 (-7.50%)
Jun 24, 2026, 1:42 PM EDT - Market open
Humacyte Market Cap
Humacyte has a market cap or net worth of $143.85 million as of June 24, 2026. Its market cap has decreased by -63.78% in one year.
Market Cap
143.85M
Enterprise Value
173.46M
1-Year Change
-63.78%
Ranking
Category
Stock Price
$0.65
Market Cap Chart
Since December 1, 2020, Humacyte's market cap has increased from $124.31M to $143.85M, an increase of 15.72%. That is a compound annual growth rate of 2.66%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 24, 2026 | 143.85M | -22.40% |
| Dec 31, 2025 | 185.37M | -71.47% |
| Dec 31, 2024 | 649.78M | 120.90% |
| Dec 29, 2023 | 294.15M | 35.19% |
| Dec 30, 2022 | 217.58M | -70.86% |
| Dec 31, 2021 | 746.77M | 471.21% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 1, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| YD Bio | 196.19M |
| Compugen | 195.79M |
| AN2 Therapeutics | 194.49M |
| Tonix Pharmaceuticals Holding | 194.48M |
| Galectin Therapeutics | 184.40M |
| Precision BioSciences | 182.68M |
| LENZ Therapeutics | 182.48M |
| Equillium | 180.83M |